Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
KBW Prem Yield Equity REIT Powershares | KBWY | Nov 25, 2024 | 19.99 | +1.37 |
KBW Prop & Casuality Insur Powershares | KBWP | Nov 25, 2024 | 124.83 | +0.52 |
KBW Regional Banking Powershares | KBWR | Nov 25, 2024 | 68.29 | +1.86 |
KE Holdings | BEKE | Nov 25, 2024 | 18.40 | -5.15 |
Kearny Financial | KRNY | Nov 25, 2024 | 8.21 | -0.73 |
Keen Vision Acquisition | KVACU | Nov 25, 2024 | 10.99 | 0.00 |
Keen Vision Acquisition | KVAC | Nov 25, 2024 | 10.87 | 0.00 |
Kellanova | K | Nov 25, 2024 | 81.11 | -0.07 |
Kelly Services A | KELYA | Nov 25, 2024 | 14.85 | +3.13 |
Kelly Services B | KELYB | Nov 25, 2024 | 15.49 | +9.11 |
Kemper | KMPR | Nov 25, 2024 | 71.95 | +0.47 |
Kennametal | KMT | Nov 25, 2024 | 29.40 | +0.96 |
Kennedy-Wilson | KW | Nov 25, 2024 | 11.21 | +1.63 |
Kenon Holdings | KEN | Nov 25, 2024 | 29.86 | +4.88 |
Kentucky First Federal Bancorp | KFFB | Nov 25, 2024 | 2.60 | -1.37 |
Kenvue | KVUE | Nov 25, 2024 | 24.24 | +0.66 |
Keros Therapeutics | KROS | Nov 25, 2024 | 56.58 | +1.18 |
Keurig Dr Pepper | KDP | Nov 25, 2024 | 32.85 | +0.58 |
Kewaunee Scientific | KEQU | Nov 25, 2024 | 42.54 | -2.65 |
Key Tronic | KTCC | Nov 25, 2024 | 5.39 | -3.92 |
KeyCorp | KEY | Nov 25, 2024 | 19.81 | +1.07 |
KeyCorp | KEY-L | Nov 25, 2024 | 25.08 | +0.32 |
Keycorp Pref E | KEY-I | Nov 25, 2024 | 25.04 | +0.04 |
Keycorp Pref F | KEY-J | Nov 25, 2024 | 23.33 | +0.82 |
Keycorp Pref G | KEY-K | Nov 25, 2024 | 23.88 | +0.63 |
Keysight Technologies | KEYS | Nov 25, 2024 | 171.68 | +0.82 |
Kezar Life Sciences | KZR | Nov 25, 2024 | 7.47 | -0.40 |
KFA Global Carbon ETF | KRBN | Nov 25, 2024 | 31.69 | +1.38 |
Kforce | KFRC | Nov 25, 2024 | 60.06 | +2.98 |
Kidpik | PIK | Nov 25, 2024 | 2.43 | +9.95 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.